Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 60
Filtrar
1.
Phys Rev E ; 100(3-1): 032304, 2019 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-31639975

RESUMO

We studied the evolution of cooperation in the framework of evolutionary game theory, implementing voluntary participation in the prisoner's dilemma. Although previous studies have tried to overcome the dilemma by introducing voluntary participation called a "loner," the question of which strategies among various strategies including voluntary participation are adaptive under competitive circumstances is still an unsolved puzzle. Here we have developed a model that consists of all possible strategies using a one-period memory of past actions. This model enables us to analyze a "melting pot" of strategies, wherein several strategies interact and compete with each other. Our results revealed that one strategy, in which one escapes if a partner defects or cooperates if a partner becomes a loner, dominates and maintains cooperation in an alternating prisoner's dilemma game. However, the so-called "win-stay, lose-shift" strategy dominates in a simultaneous prisoner's dilemma game. Our simulations clearly show that voluntary participation in the prisoner's dilemma game works in the alternating situation rather than the simultaneous one.

2.
Neurology ; 78(11): 803-10, 2012 Mar 13.
Artigo em Inglês | MEDLINE | ID: mdl-22377813

RESUMO

OBJECTIVE: RNF213 was recently reported as a susceptibility gene for moyamoya disease (MMD). Our aim was to clarify the correlation between the RNF213 genotype and MMD phenotype. METHODS: The entire coding region of the RNF213 gene was sequenced in 204 patients with MMD, and corresponding variants were checked in 62 pairs of parents, 13 mothers and 4 fathers of the patients, and 283 normal controls. Clinical information was collected. Genotype-phenotype correlations were statistically analyzed. RESULTS: The c.14576G>A variant was identified in 95.1% of patients with familial MMD, 79.2% of patients with sporadic MMD, and 1.8% of controls, thus confirming its association with MMD, with an odds ratio of 259 and p < 0.001 for either heterozygotes or homozygotes. Homozygous c.14576G>A was observed in 15 patients but not in the controls and unaffected parents. The incidence rate for homozygotes was calculated to be >78%. Homozygotes had a significantly earlier age at onset compared with heterozygotes or wild types (median age at onset 3, 7, and 8 years, respectively). Of homozygotes, 60% were diagnosed with MMD before age 4, and all had infarctions as the first symptom. Infarctions at initial presentation and involvement of posterior cerebral arteries, both known as poor prognostic factors for MMD, were of significantly higher frequency in homozygotes than in heterozygotes and wild types. Variants other than c.14576G>A were not associated with clinical phenotypes. CONCLUSIONS: The homozygous c.14576G>A variant in RNF213 could be a good DNA biomarker for predicting the severe type of MMD, for which early medical/surgical intervention is recommended, and may provide a better monitoring and prevention strategy.


Assuntos
Doença de Moyamoya/genética , Ubiquitina-Proteína Ligases/genética , Adenosina Trifosfatases , Adolescente , Adulto , Idade de Início , Biomarcadores , Infarto Cerebral/etiologia , Criança , Pré-Escolar , DNA/genética , Análise Mutacional de DNA , Epilepsia/complicações , Família , Feminino , Estudos de Associação Genética , Predisposição Genética para Doença , Variação Genética , Genótipo , Homozigoto , Humanos , Lactente , Recém-Nascido , Deficiência Intelectual/complicações , Deficiência Intelectual/psicologia , Masculino , Pessoa de Meia-Idade , Doença de Moyamoya/patologia , Fenótipo , Artéria Cerebral Posterior/patologia , Valor Preditivo dos Testes , Caracteres Sexuais , Adulto Jovem
3.
Clin Genet ; 80(5): 484-8, 2011 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-21062273

RESUMO

Ohtahara syndrome (OS) is one of the most severe and earliest forms of epilepsy. We have recently identified that the de novo mutations of STXBP1 are important causes for OS. Here we report a paternal somatic mosaicism of an STXBP1 mutation. The affected daughter had onset of spasms at 1 month of age, and interictal electroencephalogram showed suppression-burst pattern, leading to the diagnosis of OS. She had a heterozygous c.902+5G>A mutation of STXBP1, which affects donor splicing of exon 10, resulting in 138-bp insertion of intron 10 sequences in the transcript. The mutant transcript had a premature stop codon, and was degraded by nonsense-mediated mRNA decay in lymphoblastoid cells derived from the patient. High-resolution melting analysis of clinically unaffected parental DNAs suggested that the father was somatic mosaic for the mutation, which was also suggested by sequencing. Cloning of PCR products amplified with the paternal DNA samples extracted from blood, saliva, buccal cells, and nails suggested that 5.3%, 8.7%, 11.9%, and 16.9% of alleles harbored the mutation, respectively. This is a first report of somatic mosaicism of an STXBP1 mutation, which has implications in genetic counseling of OS.


Assuntos
Epilepsia/genética , Mosaicismo , Proteínas Munc18/genética , Espasmos Infantis/genética , Pai , Feminino , Humanos , Lactente , Recém-Nascido , Masculino
4.
In. Zenebon, Odair; Pascuet, Neus Sadocco. Métodos físico-químicos para análise de alimentos. Brasília, Brasil. Ministério da Saúde, 4 ed; 2005. p.735-754. (Série A. Normas e Manuais Técnicos).
Monografia em Português | Sec. Est. Saúde SP, SESSP-CTDPROD, Sec. Est. Saúde SP, SESSP-ACVSES, SESSP-IALPROD, Sec. Est. Saúde SP, SESSP-IALACERVO | ID: biblio-1070467
5.
J Mater Sci Mater Med ; 15(7): 817-23, 2004 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-15387418

RESUMO

Porous hydroxyapatite (HAp) ceramics possessing well-controlled porosities and pore sizes were developed by firing apatite-fiber compacts mixed with carbon beads and agar. The total porosities could be controlled in the range from 40 to 85% by varying compaction pressure (20-40 MPa), firing temperature (1000-1300 degrees C) and carbon/HAp ratio (0/10-10/10 (w/w)). Most of the pores were regarded as open pores. The pore sizes were mainly affected by the carbon-bead diameter (5, 20 or 150 microm) and partly by the compaction pressure and the firing temperature. The pore sizes of the porous HAp ceramics derived from the carbon beads of 150 microm in diameter were distributed in the two separate ranges of several micrometers and more than 100 microm.


Assuntos
Cerâmica , Durapatita/química , Teste de Materiais , Microscopia Eletrônica de Varredura , Porosidade , Espectroscopia de Infravermelho com Transformada de Fourier , Termodinâmica , Difração de Raios X
6.
Phytopathology ; 89(12): 1186-92, 1999 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-18944644

RESUMO

ABSTRACT The elicitation of the hypersensitive response (HR) is known to depend on the interaction between a resistance gene of a host plant and a corresponding avirulence gene of a pathogen. The cv. Kurodane-Sanjaku of cowpea (Vigna unguiculata) has the Cry locus that confers resistance against cucumber mosaic virus strain Y (CMV-Y). The resistance is overcome by infection with a legume strain of CMV (CMV-L). RNA 2, which codes for the 2a protein, a subunit of the viral replicase components, has been known to control virulent/avirulent phenotypes. We generated chimeric constructs of full-length cDNA clones of RNA 2 of both strains and inoculated infectious transcripts to delimit the domain controlling symptoms. A 243-base pair fragment containing a coding region for the GDD RNA-dependent RNA polymerase core sequence was shown to be responsible for the phenotypic differences. From sequence alignment analysis, two amino acids (Phe631 and Ala641) of the HR-type 2a protein encoded in this fragment were specifically exchanged to Tyr and Ser, respectively, in the 2a proteins of resistance-breaking strains. Point mutations introduced into RNA 2 backgrounds of both strains that were designed to change the amino acid at position 631 resulted in a change of symptoms, indicating that a single nucleotide change determines the reactions elicited by both strains. Analysis for one additional mutant RNA 2 showed that symptom determination may be correlated with the nature of the lateral chain of amino acid 631.

7.
Rev Saude Publica ; 31(2): 140-3, 1997 Apr.
Artigo em Português | MEDLINE | ID: mdl-9497560

RESUMO

INTRODUCTION: A factory producing lead ingots, located in Caçapava, caused lead and cadmium contamination of the environment, in the Paraiba Valley region of Southeastern, Brazil, through the discharge of industrial waste and the recycling of batteries. The factory, set in a rural, dairy cattle breeding area, worried sanitary authorities who envisaged the possibility of these metals' having entered the food chain. For the purpose of assessing the levels of contamination of the milk produced in the region, due to the cattle's possible consumption of contaminated grass and water, the amounts of cadmium and lead present in the milk were verified. MATERIAL AND METHOD: Major producers, covering an area of up to 20 km from the contaminated source, authorized collection of 218 samples of both pasteurized and non-pasteurized milk, which were analysed. Lead and cadmium levels were determined by flame atomic absorption spectrophotometry, the lead being pre-concentrated by complexation with APDC (ammonium 1-pyrrolidinecarbodithioate) and further extraction with isobutyl methylketone. RESULTS AND CONCLUSIONS: Of the total number of samples, 43 presented lead levels over the maximum limit of 0.05 mg/kg established by Brazilian legislation. The median value found for lead was 0.04 mg/L. The variance analysis, with 95% confidence level, found no significant difference among the types of milk studied with regard to lead levels. As for cadmium, all samples showed levels below the 0.02 mg/L quantification limit of the method. In spite of the environmental contamination, the levels of cadmium found in the milk were below the 1.0 mg/kg limit established by Brazilian legislation.


Assuntos
Cádmio/análise , Contaminação de Alimentos/análise , Chumbo/análise , Leite/química , Animais , Brasil , Resíduos Industriais , Poaceae , Poluentes Químicos da Água
8.
Circulation ; 95(1): 245-51, 1997 Jan 07.
Artigo em Inglês | MEDLINE | ID: mdl-8994443

RESUMO

BACKGROUND: Although calcium channel blockers have not been shown to be beneficial for the treatment of patients with heart failure, a recent clinical trial demonstrated a favorable effect of amlodipine on the survival of patients with heart failure resulting from nonischemic dilated cardiomyopathy. We investigated the effects of amlodipine on a murine model of congestive heart failure induced by the M variant of encephalomyocarditis virus (EMCV). METHODS AND RESULTS: Four-week-old male DBA/2 mice were inoculated with EMCV and administered amlodipine, diltiazem, or vehicle PO for 2 weeks. The heart weight-to-body weight ratio and the histopathological grades of myocardial lesions were significantly lower and survival was significantly increased in the amlodipine-treated group (P < .01, P < .05, and P < .05, respectively) than in the control group. In vitro, amlodipine added to murine J774A.1 macrophages concomitant with EMCV inhibited nitrite formation in a concentration-dependent manner, but diltiazem did not. Furthermore, NG-monomethyl-L-arginine, an inhibitor of NO synthesis, decreased myocardial lesions significantly in this murine model. Immunohistochemistry revealed that the number of cells stained with antibody against an inducible NO synthase decreased significantly in the amlodipine-treated group compared with that in the control group (P < .01). CONCLUSIONS: Amlodipine appears to have a protective effect against myocardial injury in this animal model of congestive heart failure. The therapeutic effect of amlodipine may be in part resulting from inhibition of overproduction of NO.


Assuntos
Anlodipino/uso terapêutico , Bloqueadores dos Canais de Cálcio/uso terapêutico , Insuficiência Cardíaca/tratamento farmacológico , Óxido Nítrico/biossíntese , Anlodipino/farmacologia , Animais , Peso Corporal , Bloqueadores dos Canais de Cálcio/farmacologia , Infecções por Cardiovirus/complicações , Modelos Animais de Doenças , Vírus da Encefalomiocardite/isolamento & purificação , Coração/anatomia & histologia , Coração/virologia , Insuficiência Cardíaca/virologia , Masculino , Camundongos , Camundongos Endogâmicos DBA , Miocardite/virologia , NG-Nitroarginina Metil Éster/farmacologia , Óxido Nítrico/antagonistas & inibidores , Tamanho do Órgão
9.
Life Sci ; 59(10): PL121-5, 1996.
Artigo em Inglês | MEDLINE | ID: mdl-8761321

RESUMO

We investigated the effects of inotropic agents with phosphodiesterase III inhibitory properties, amrinone, pimobendan and vesnarinone, and cell permeable cyclic nucleotide analogue, 8-bromo adenosine 3'5'-cyclic monophosphate (8 Br-cAMP) on the induction of nitric oxide synthase (NOS) by lipopolysaccharide in J774A.1 macrophages in vitro. Although all three inotropic agents inhibited nitrite accumulation, the degree of inhibition was different, with pimobendan being the most potent inhibitor and amrinone the least. Vesnarinone inhibited nitrite formation biphasically. 8 Br-cAMP increased nitrite production at high concentrations, suggesting that the inhibitory effects of inotropic agents could not be explained by an increase in cAMP. Although differential inhibition of inducible NOS by inotropic agents may explain the different effects of these drugs in patients with heart failure, further study is necessary to reach this conclusion.


Assuntos
Cardiotônicos/farmacologia , Lipopolissacarídeos/farmacologia , Macrófagos/efeitos dos fármacos , Óxido Nítrico Sintase/biossíntese , Inibidores de Fosfodiesterase/farmacologia , 8-Bromo Monofosfato de Adenosina Cíclica/farmacologia , Amrinona/farmacologia , Animais , Linhagem Celular , Meios de Cultura , Macrófagos/enzimologia , Macrófagos/metabolismo , Camundongos , Óxido Nítrico Sintase/antagonistas & inibidores , Nitritos/metabolismo , Pirazinas , Piridazinas/farmacologia , Quinolinas/farmacologia
10.
Circ Res ; 77(3): 486-93, 1995 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-7543825

RESUMO

Unlike large-vessel endothelial cells in cell culture, cardiac microvascular endothelial cells (CMEC) isolated from adult rat ventricular muscle exhibit little detectable constitutive nitric oxide (NO) synthase activity after isolation in vitro but respond to specific combinations of inflammatory mediators with an increase in inducible NO synthase (iNOS; type 2 NO synthase) activity. CMEC iNOS is induced by soluble inflammatory mediators in lipopolysaccharide-activated rat alveolar macrophage-conditioned medium at 24 hours, and this induction can be partially prevented by either interleukin-1 (IL-1) receptor antagonist or a polyclonal anti-rat tumor necrosis factor-alpha (TNF-alpha) antiserum. Interferon-gamma (IFN-gamma), which by itself does not induce iNOS in CMEC, potentiates and accelerates iNOS induction by IL-1 beta. Transforming growth factor-beta (TGF-beta) decreases iNOS activity, protein content, and mRNA abundance in IL-1 beta- and IFN-gamma-pretreated CMEC. To determine whether NO released by CMEC would affect myocyte contractile function in vitro, freshly isolated ARVM were allowed to settle onto confluent, serum-starved CMEC that had been pretreated for 24 hours with IL-1 beta, a cytokine that alone does not affect myocyte contractile function in vitro. Baseline contractile amplitude, at 2 Hz and 37 degrees C, of myocytes in heterotypic culture with IL-1 beta-pretreated CMEC was not different from that of myocytes in control, homotypic myocyte cultures. However, cocultured myocytes exhibited decreased contractile responsiveness to 2 nmol/L isoproterenol compared with control cells, and this could be reversed by the addition of 1 mmol/L NG-monomethyl-L-arginine, an inhibitor of NOS.(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Aminoácido Oxirredutases/biossíntese , Endotélio Vascular/enzimologia , Isoproterenol/farmacologia , Contração Miocárdica/efeitos dos fármacos , Animais , Células Cultivadas , Ventrículos do Coração , Interleucina-1/farmacologia , Lipopolissacarídeos/farmacologia , Masculino , Óxido Nítrico/fisiologia , Óxido Nítrico Sintase , Ratos , Ratos Sprague-Dawley , Fator de Crescimento Transformador beta/farmacologia
11.
Circ Res ; 77(3): 494-502, 1995 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-7543826

RESUMO

Recent evidence has documented that increased activity of an inducible nitric oxide synthase (iNOS; type 2 NO synthase) in primary isolates of adult rat ventricular myocytes after exposure to soluble mediators in medium conditioned by lipopolysaccharide-activated macrophages is associated with a decrease in their contractile responsiveness to beta-adrenergic agonists. It remained unclear which specific inflammatory cytokines in this medium contribute to the induction of iNOS activity in myocytes and whether induction of iNOS would result in an obligatory decline in contractile function. Interleukin (IL)-1 beta and tumor necrosis factor-alpha (TNF-alpha) were both present in the lipopolysaccharide-activated macrophage-conditioned medium. However, only IL-1 receptor antagonist and not an anti-rat TNF-alpha antiserum diminished the extent of iNOS induction in myocytes exposed to this medium and prevented a decline in contractile responsiveness to isoproterenol. When recombinant cytokines were used, IL-1 beta, TNF-alpha, and IFN-gamma each induced iNOS activity in cardiac myocytes at 24 hours. However, only the combination of IL-1 beta and IFN-gamma reproducibly caused contractile dysfunction in cardiac myocytes. Among the constituents of the defined medium routinely used for maintenance of adult rat ventricular myocytes in primary culture, it was noted that insulin (10(-7) mol/L) was required for NO production, as detected by nitrite release in cytokine-pretreated myocytes, although insulin had no effect on the extent of induction of iNOS mRNA or maximal enzyme activity in myocyte cell lysates.(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Agonistas Adrenérgicos beta/farmacologia , Aminoácido Oxirredutases/biossíntese , Citocinas/farmacologia , Contração Miocárdica/efeitos dos fármacos , Miocárdio/enzimologia , Animais , Insulina/farmacologia , Interferon gama/farmacologia , Proteína Antagonista do Receptor de Interleucina 1 , Lipopolissacarídeos/farmacologia , Macrófagos/fisiologia , Masculino , Óxido Nítrico Sintase , Ratos , Ratos Sprague-Dawley , Sialoglicoproteínas/farmacologia , Fator de Necrose Tumoral alfa/farmacologia
14.
Br Poult Sci ; 35(1): 47-58, 1994 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-8199890

RESUMO

1. Two-way selection for delayed-type hypersensitivity wattle reaction (DWR) competence to BCG antigen was carried out over 4 generations, using a flock of White Leghorn chickens. DWR was measured by intradermal injection of BCG into the wattle of chickens. 2. Selection for DWR was effective. The generation means of average selection differential, selection response and realized heritability were 1.15 mm, 0.77 mm and 0.70 respectively. Correlated responses were found in body weight, egg weight and hatchability. In all of these traits, the L line (selected for low wattle reaction) showed higher values than the H line (high reaction). 3. Specific trends in gene frequencies were observed at the major histocompatibility B and alkaline phosphatase Akp loci. 4. Significant line differences were found in graft-versus-host reaction competence and Marek's disease resistance. In both characters, the L line was higher than the H line. No line differences were found in phytohaemagglutinin response, phagocytic activity or immune responses.


Assuntos
Galinhas/imunologia , Crista e Barbelas/imunologia , Hipersensibilidade Tardia/veterinária , Mycobacterium bovis/imunologia , Seleção Genética , Animais , Peso Corporal , Feminino , Frequência do Gene , Hipersensibilidade Tardia/genética , Doença de Marek/imunologia , Oviposição , Polimorfismo Genético
16.
Biophys J ; 64(4): 1344-53, 1993 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-19431888

RESUMO

Molecular dynamics (MD) calculation of the fluid phase lauryl alcohol-laurate bilayer has been executed based on Berendsen's surface-constrained model. Structure and dynamics of the bilayer have been investigated by analyzing the trajectories of the chain configurations. Newly defined correlation functions as well as the conventional ones showed that the tilt and bend of the chain play an important role in the bilayer structure, including behavior of the order parameter. Interpenetration of the layers as well as formation of collectively ordered small domains was also found. The calculated lateral diffusion coefficient was in satisfactory agreement with the experimental one. Successive jumps of the head group, rather than the hydrodynamic continuous motion, were observed. Between the jumps, the molecule librated in a local site. Time-dependent autocorrelation functions showed evidence of several different modes of the chain motion, whose time constant ranged from a few tenths of picoseconds to several tens of picoseconds.

17.
Int J Exp Pathol ; 73(6): 721-31, 1992 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-1337265

RESUMO

The presence of the viral RNA in the myocardium in experimental coxsackievirus B3 myocarditis of mice was investigated using the polymerase chain reaction (PCR). Four-week-old C3H/He mice (n = 35) were inoculated with coxsackievirus B3 (Nancy strain, 10(5) plaque-forming units/mouse). We used a pair of primers, which encompass a part of the 5' end sequence of the coxsackievirus B3 genome and can also detect many enteroviral RNAs. We found that hearts were positive for the viral RNA from 2 to 21 days after virus inoculation by PCR, but negative after day 28 and in non-infected control mice (n = 5). The viral RNA were detected by PCR later than by culture. Thus, the detection of the viral RNA using enzymatic amplification is more rapid and easier and may be more useful for clinical diagnosis of viral myocarditis than conventional culture methods. However, virus persistence in the myocardium long after virus inoculation is unusual in this model.


Assuntos
Infecções por Coxsackievirus/microbiologia , Enterovirus Humano B/isolamento & purificação , Coração/microbiologia , Miocardite/microbiologia , RNA Viral/análise , Animais , Southern Blotting , Infecções por Coxsackievirus/patologia , Eletroforese em Gel de Ágar , Camundongos , Camundongos Endogâmicos C3H , Miocardite/patologia , Miocárdio/patologia , Reação em Cadeia da Polimerase
18.
Jpn Circ J ; 56(11): 1138-45, 1992 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-1360548

RESUMO

The purpose of this study was to investigate the therapeutic effect of an alpha 1-blocker, bunazosin, using an experimental murine model of congestive heart failure induced by viral myocarditis. This model is characterized by a high incidence of severe myocarditis and subsequent congestive heart failure, and is suitable for the evaluation of the effect of drugs. To estimate myocardial damage objectively and quantitatively, we used antimyosin monoclonal antibody in addition to histopathological grading. Four-week-old BALB/c mice were inoculated with encephalomyocarditis virus. The mice were injected daily with bunazosin or saline as a placebo from the day of viral inoculation until day 7 (protocol-I) or day 14 (protocol-II), or from day 4 to day 14 (protocol-III). They were then injected with 1.5 microCi of indium-111 labeled antimyosin antibody and were killed 24 h later. The antimyosin cardiac uptake was counted and histopathological grading was performed. The heart-weight to body-weight ratio, left ventricular dimension, histopathological grades and antimyosin cardiac uptake were significantly lower in the bunazosin group than in the placebo group in protocol-II, but not in protocol-I or protocol-III. Bunazosin showed a protective effect against viral myocarditis only when it was started early after infection and continued until the stage of congestive heart failure.


Assuntos
Antagonistas Adrenérgicos alfa/uso terapêutico , Vírus da Encefalomiocardite , Infecções por Enterovirus , Insuficiência Cardíaca/tratamento farmacológico , Miocardite/microbiologia , Quinazolinas/uso terapêutico , Antagonistas Adrenérgicos alfa/administração & dosagem , Animais , Modelos Animais de Doenças , Insuficiência Cardíaca/etiologia , Insuficiência Cardíaca/prevenção & controle , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Miocardite/complicações , Miocárdio/patologia , Quinazolinas/administração & dosagem
19.
Magn Reson Med ; 27(2): 238-46, 1992 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-1461111

RESUMO

A nuclear magnetic resonance (NMR) imaging and display method for the observation of the continuous motion of objects is presented. By modifying a line scan technique, the spin-density distribution along a line is displayed in succession. Although spatial information is limited to only one dimension, the motion of the object is recorded at intervals of 55 ms by using a commercially available NMR imaging system. In a phantom study, this method yielded accurate velocity measurements along a single axis. When the method was applied to the human chest, an image analogous to that of M-mode echocardiography was obtained. This method, which can be called spin-echo M-mode NMR imaging, approaches the functional analysis of cardiac wall motion in regions where echocardiography is not possible. The effects of respiratory motion on the left ventricular wall were recorded in addition to its intrinsic contractile motion in an image obtained along a line parallel to the cranio-caudal axis of the body. The advantages of this method to assess cardiac wall motion in a patient with an arrhythmia were also demonstrated.


Assuntos
Aumento da Imagem/métodos , Imageamento por Ressonância Magnética/métodos , Fibrilação Atrial/fisiopatologia , Coração/fisiologia , Coração/fisiopatologia , Humanos , Modelos Estruturais , Movimento (Física) , Contração Miocárdica/fisiologia , Respiração/fisiologia , Função Ventricular Esquerda/fisiologia
20.
J Lab Clin Med ; 120(4): 569-73, 1992 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-1328433

RESUMO

The effects of combined treatment with ribavirin and recombinant human leukocyte interferon-alpha A/D against Coxsackievirus B3 replication were investigated in cultured cells. Recombinant human leukocyte interferon-alpha A/D was applied 12 hours before Coxsackievirus B3 inoculation and ribavirin was applied 1 hour after Coxsackievirus B3 inoculation on FL (human amnion) cell monolayers. These drugs inhibited Coxsackievirus B3 replication synergistically by plaque-reduction assay. This method of applying drugs may be useful in preventing and treating Coxsackie B virus infection.


Assuntos
Enterovirus Humano B/efeitos dos fármacos , Enterovirus Humano B/fisiologia , Interferon Tipo I/farmacologia , Ribavirina/farmacologia , Replicação Viral/efeitos dos fármacos , Linhagem Celular , Sinergismo Farmacológico , Humanos , Interferon Tipo I/administração & dosagem , Proteínas Recombinantes , Ribavirina/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...